Although our analysis of public single-cell sequencing datasets revealed upregulation of PLEKHA5 in melanoma patients with brain metastasis, the elevated expression of the PLEKHA5-L isoform requires further validation using advanced splicing analysis technologies capable of resolving isoform-specific contributions in heterogeneous tumor contexts (17). The gene discussed is PLEKHA5; the disease is neoplasm.